Fresh analysis suggests that patients who discontinue blockbuster weight-loss injections like Wegovy and Mounjaro tend to recover lost weight far faster than those who stop traditional lifestyle plans.
Published data in a leading health publication demonstrates that while overweight people frequently drop a large proportion of their total mass while undergoing treatment, the mass returns at an average rate of nearly a kilo each month upon discontinuation.
"Individuals using these treatments need to be informed of the potential of fast weight regain when the therapy concludes," stated lead investigator Dr. Susan Jebb.
That rate of recovery suggests a return to pre-treatment mass within about one and a half years.
Weighing Therapies
The analysis, which examined dozens of trials involving over 9,000 of patients, compared the results of GLP-1 agonists with older methods.
The team point out that individuals who shed pounds through dieting generally have a more gradual weight regain—approximately 0.1 kg a month—post-intervention.
Understanding the Fast Rebound
Doctors suggest the mode of action of the jabs accounts for the accelerated weight return.
These medications copy a natural hormone called GLP-1, which controls feelings of fullness.
"Sustained high doses of GLP-1 levels far above than normal could lead to the system to produce less of its own natural hormone, and could reduce sensitivity to its effects," said Dr. Adam Collins, a dietetics researcher.
"Withdrawal of this medication means hunger is no longer kept in check, making excessive eating a significant risk."
A Chronic Disease?
The NHS recommend the jabs for individuals with obesity-related health risks, alongside recommended lifestyle changes.
A number of clinicians argue that, given the significant potential of weight regain, the treatment might need to be ongoing.
This perspective is reinforced by drug manufacturers, who state that the results "emphasize the persistent character of excess weight," similar to managing conditions like diabetes.
User Testimonies
Individuals who have discontinued the medication explain a intense return of appetite.
"It felt as if something flipping and you're instantly extremely hungry," described a patient.
This challenge is compounded if individuals have not adopted permanent dietary or behavioural changes during treatment.
Growing Adoption
Recent estimates suggest that millions of adults in the UK have tried these injections in the last 12 months, with demand continuing to grow.
- Use is higher among women than men.
- The 40s and 50s demographic shows the highest level of interest.
- Many obtain the drugs through private prescriptions rather than public health services.
Finally, researchers stress that while GLP-1 drugs are powerful agents for weight loss, they are not a standalone solution and lasting health benefits likely depends on integrated behavioural support.
